A close icon

Interested in becoming an advocate?

Oops! Something went wrong while submitting the form.
Back to main page


Once a week subcutaneous injection

Ozempic (generic name: Semaglutide) is a GLP-1 agonist FDA approved for the treatment of type 2 diabetes.

Zepbound (generic name: Tirzepatide) is a GLP-1/GIP receptor agonist drug that can result in substantial weight loss. It is FDA approved to help adults with overweight or obesity.

How does



  • acts on brain signaling to reduce food intake
  • helps control blood sugar levels by increasing the release of insulin from the pancreas
  • slows down food leaving your stomach, thus, keeping you fuller for longer

Common side effects of


  • nausea
  • vomiting
  • decreased appetite
  • diarrhea
  • stomach (abdominal) pain
  • constipation

You can find more information here:

Expected Results: 

  • Individuals on Zepbound lost an average of 21% of their body weight
  • Helps control blood sugar levels
  • Decreased HgbA1C

Do not take


if you:

  • have or any of your family members have ever had medullary thyroid carcinoma (MTC) or if you have MEN2
  • are pregnant, planning to become pregnant or breastfeeding
  • have or have had history of pancreatitis
  • history of chronic malabsorption
  • history of gallbladder disease
  • have a history of gastroparesis or IBD
  • are allergic to tirzepatide or any of the ingredients* in Zepbound

*non-medicinal ingredients in Zepbound: sodium chloride, sodium phosphate dibasic heptahydrate, and water for injection. Hydrochloric acid solution and/or sodium hydroxide solution may have been added to adjust the pH.

Disclaimer: Please note that the following list may not encompass all potential side effects or drug interactions. To determine if any drug or supplement you are currently taking could interact with a medication, we strongly advise consulting your healthcare provider or pharmacist. Seek medical advice immediately if you experience any adverse reaction.